20
Participants
Start Date
July 31, 2007
Primary Completion Date
August 3, 2015
Study Completion Date
August 3, 2015
Avastin
"Initial Treatment Bevacizumab 15mg/kg Day 1 IV every 21 days x 5 cycles (beginning with cycle 2)~Consolidation Treatment:~Avastin 15mg/kg IV every 21 days x 12 cycles"
Paclitaxel
Paclitaxel 135mg/m2 IV Day 1 every 21 days x 6 cycles
Cisplatin
75mg/m2 IP day 2 every 21 days x 6 cycles
University of Oklahoma Health Sciences Center, Oklahoma City
Collaborators (1)
Genentech, Inc.
INDUSTRY
University of Oklahoma
OTHER